Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
S. Stephan-Falkenau (Berlin, Germany). Modern profiling of advanced lung cancer at the primary diagnosis and during therapy. International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer

Member's Comments

No comment yet.

Related content which might interest you: Successful targeted therapy of advanced lung cancer Source: Annual Congress 2013 –Grand Round on diagnostic and therapeutic challenges in thoracic oncology: an interactive session Year: 2013 Current neoadjuvant/adjuvant treatment for advanced stage lung cancer Source: International Congress 2014 – PG19 Surgery for advanced stage lung cancer Year: 2014 Advances in target therapy for lung cancer Source: International Congress 2014 – Ceremony for the ERS Romain Pauwels Research Award 2014 - Clinical Year in Review I Year: 2014 Advances in target therapy in lung cancer Source: Eur Respir Rev 2015; 24: 23-29 Year: 2015 Dealys in the diagnosis and treatment of lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 458s Year: 2004 Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy Source: Eur Respir J 2012; 39: 1437-1442 Year: 2012 PG11 Modern approaches in lung cancer diagnostics and therapy Source: Paris 2018 - Educational material Year: 2018 Possibilities of palliative combined therapy for extensive nonsmall cells lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 378s Year: 2001 Challenges in molecular testing in lung cancer patients with advanced disease Source: International Congress 2016 – Lung cancer: latest developments in screening and patient management Year: 2016 Novel approaches in metastasised non-small cell lung cancer with a special focus on modern systemic therapies Source: International Congress 2019 – State of the art session: Thoracic oncology Year: 2019 Utilisation of biomarker testing to guide therapy in non-small cell lung cancer in a regional lung cancer service Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018 The method of individualisation of treatment and prognosis for advanced non-small cell lung cancer Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010 Evolution in the diagnostic approach to lung cancer Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021 Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer Source: Eur Respir J 2013; 42: 1119-1133 Year: 2013 A preliminary study on targeted therapies in advanced lung cancer patients Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009 Effectiveness of chemotherapy for advanced lung cancer in the elderly Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009 Locally advanced and metastatic lung cancer management delay: Tunisian department experience Source: International Congress 2016 – Quality management and quality of life in lung cancer Year: 2016 Treatment of non-microcelular lung cancer in its advanced stage Source: Annual Congress 2008 - Treatment of thoracic tumours Year: 2008